Home/ Supplements/ Nmn/ Lipo NMN

Lipo NMN

product on market Capsule Renue By Science Safety: 60/100
60/100

Review before taking

  • Beta-Nicotinamide Mononucleotide: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Beta-Nicotinamide Mononucleotide is researched for its role in boosting NAD+ levels to support cellular energy. Evidence for these effects in humans remains limited due to low overall coverage. A safety score of 60 indicates potential concerns that warrant caution.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Beta-Nicotinamide Mononucleotide: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains 500mg of Beta-Nicotinamide Mononucleotide, which is over 14 times the recommended upper intake limit.

Label

Product Label

Label for Lipo NMN
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Vegetarian Capsule(s)
Serving Size
45
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Exceeds UL by 14.3× (UL: 35 mg) 196 studies (A:5, B:63)

Other Ingredients

Hypromellose Microcrystalline Cellulose Sunflower Lecithin Rice Flour
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use Take two (2) capsules daily with or without food. May be taken with or without food.

Warnings & Precautions

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using.

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using.

Do not use if safety seal is broken or missing.

Formulation Notes

Lipo NMN is formulated with patented liposome technology designed to protect Beta - Nicotinamide Mononucleotide (NMN) through the gastrointestinal tract and bloodstream to reach cells and tissues throughout the body intact.

This product is manufactured in the United States at a FDA registered facility under strict GMP standards.

Powdered Liposomes

Liposomal capsules

No artificial colors, flavors or preservatives. Non-GMO.

Suitable for vegans.

Additional Information

Store in a cool, dry place.

GMP Good Manufacturing Practice Certified

Metadata

Product Details

UPC / SKU6 56165 99656 8
DSLD Entry Date2024-09-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID319021
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
54
Avg Quality
4
Rct
2
Meta Analysis
2
Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025 PubMed DOI
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024 PubMed DOI
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.) PubMed DOI
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience PubMed DOI
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024 PubMed DOI
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023 PubMed DOI
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →
Compare

Similar Products

View all Nmn products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.